ReviewDrug design, development and therapy2018

Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence.

Kenichi Morikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.